Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression
Tumors feature elevated sialoglycoprotein content. Sialoglycoproteins promote tumor progression and are linked to immune suppression via the sialic acid-Siglec axis. Understanding factors that increase sialoglycoprotein biosynthesis in tumors could identify approaches to improve patient response to...
Main Authors: | Kevin James Metcalf, Mary-Kate Hayward, Eric Berens, Alastair J. Ironside, Connor Stashko, E. Shelley Hwang, Valerie M. Weaver |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Matrix Biology Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590028522000059 |
Similar Items
-
Siglecs as Therapeutic Targets in Cancer
by: Jackwee Lim, et al.
Published: (2021-11-01) -
Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?
by: Chirag Dhar
Published: (2023-04-01) -
Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
by: Elena Gianchecchi, et al.
Published: (2021-05-01) -
Current Status on Therapeutic Molecules Targeting Siglec Receptors
by: María Pia Lenza, et al.
Published: (2020-12-01) -
Sialic Acid-Siglec-E Interactions During Pseudomonas aeruginosa Infection of Macrophages Interferes With Phagosome Maturation by Altering Intracellular Calcium Concentrations
by: Kaustuv Mukherjee, et al.
Published: (2020-02-01)